ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disparities"

  • Abstract Number: 2529 • ACR Convergence 2024

    Improving Outcomes and Narrowing Disparities in Juvenile Idiopathic Arthritis (JIA): A Division-Wide, Equity-Focused Quality Improvement Project

    Dori Abel1, Kirsten Spichiger2, Megan Roman2, William Baar2, Claire O'Malley2, Jay Mehta1, Terri Al'Hadi2, Kerry Ferraro3, Denique Butler2, Asia Wilson-Sanders2, Catherine Lewis2, Danielle Dodson4 and Jon Burnham1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, 3JIA parent and CHOP volunteer, Lower Gwynedd, PA, 4The Children's Hospital of Philadelphia, Philadelphia

    Background/Purpose: Although new therapeutics and treat-to-target interventions have improved JIA care, pronounced racial and ethnic outcome disparities persist. At our center, the mean population-level clinical Juvenile…
  • Abstract Number: 0181 • ACR Convergence 2024

    Integrated Multidisciplinary Lupus Social Work Program to Manage Social Determinants of Health in SLE and Lupus Nephritis – Preliminary Results

    Kimberly DeQuattro1, Stephanie DeVaughn2, Andrew Kanoff3 and Abdallah Geara1, 1University of Pennsylvania, Philadelphia, PA, 2Uniersity of Pennsylvania, Pennsylvania, 3University of Pennsylvania, Philadelphia, PA, Philadelphia, PA

    Background/Purpose: Minoritized individuals with systemic lupus erythematosus (SLE) experience social determinants of health (SDOH) challenges that affect access to care and increase the risk for…
  • Abstract Number: 0404 • ACR Convergence 2024

    Methotrexate Adherence in JIA: Use of Electronic Health Record-Linked Pharmacy DispensingData

    Dori Abel1, David Anderson1, Michael Kallan2, Levon Utidjian3, Jon Burnham4, Joyce Chang5, Chen Kenyon3 and Sabrina Gmuca1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, 3Children's Hospital of Philadelphia, Philadelphia, 4Children's Hospital of Philadelphia, Bryn Mawr, PA, 5Boston Children's Hospital, Boston, MA

    Background/Purpose: The extent to which adherence to prescribed treatment regimens contributes to differential disease outcomes in JIA – and demographic disparities in these outcomes –…
  • Abstract Number: 1028 • ACR Convergence 2024

    Assessment of Patient-Reported Outcomes in Juvenile Idiopathic Arthritis by Race, Ethnicity, and Insurance Type in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry

    Julia Harris1, Nancy Pan2, Catherine Bingham3, Sheetal Vora4, Cagri Yildirim-Toruner5, Kerry Ferraro6, Erik Friedrichsen7, Michelle Batthish8, Jon Burnham9, Danielle Fair10, Suhas Ganguli11, Mileka Gilbert12, Beth Gottlieb13, Olha Halyabar14, Melissa Hazen15, Tzielan Lee16, Daniel Lovell17, Melissa Mannion18, Edward Oberle19, Linda Ray20, Michael Shishov21, Mary Toth22 and Esi Morgan23, 1Children's Mercy Kansas City, Overland Park, KS, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 3Penn State Children’s Hospital, Hershey, 4Atrium Health Levine Children's Hospital, Charlotte, NC, 5Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 6JIA parent and CHOP volunteer, Lower Gwynedd, PA, 7Seattle Children's Hospital, Seattle, 8McMaster Children's Hospital, Hamilton, ON, Canada, 9Children's Hospital of Philadelphia, Philadelphia, PA, 10Medical College of Wisconsin/Children's Wisconsin, Wauwatosa, WI, 11Hackensack University Medical Center, Hackensack, 12Medical University of South Carolina, Charleston, SC, 13Cohen Children's Medical Center, Lake Success, NY, 14Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 15Boston Children's Hospital, Boston, MA, 16Stanford University School of Medicine, Palo Alto, CA, 17Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 18University of Alabama at Birmingham, Birmingham, AL, 19Nationwide Children's Hospital, Columbus, OH, 20University of Mississippi Medical Center, Jackson, MS, 21Phoenix Children's Hospital, Phoenix, AZ, 22Nemours Foundation, Orlando, FL, 23Seattle Children's Hospital, Seattle, WA

    Background/Purpose: As healthcare moves towards more patient-centered care, it is increasingly important to integrate patients’ opinions into clinical assessments and decision-making. The Pediatric Rheumatology Care…
  • Abstract Number: 1910 • ACR Convergence 2024

    Appointment Adherence: Impact of Health Portal Access, Letters, Phone Calls and Text Message Reminders in Underserved Population

    Dina Ismail1, Fatema Ezzy2 and Milena Vukelic3, 1Albert Einstein College of Medicine, Bronx, NY, 2Jacobi Medical Center/Albert Einstein College of Medicine, New York, NY, 3Louisiana State University, New York City, NY

    Background/Purpose: Missed appointments in rheumatology are reported to be up to 40%. Non-adherence to outpatient visits is contributing to poor outcomes and low income population is considered especially vulnerable. In New…
  • Abstract Number: 2551 • ACR Convergence 2024

    Modified Delphi Process to Propose an Equity Measurement Roadmap in Rheumatology

    Sancia Ferguson1, Allen Anandarajah2, Melissa Wells3, Delamo Bekele4, Ashira Blazer5, Cynthia Crowson4, Deborah Desir6, Elizabeth Ferucci7, Wambui Machua8, Esi Morgan9, Wendy Rogers10, Lauren Smith11, JoAnn Zell12, Lisa Suter13, Shraddha Jatwani14 and Christie Bartels15, 1University of Wisconsin, Madison, Madison, WI, 2University of Rochester Medical Center, Rochester, NY, 3McFarland Clinic, Ames, IA, 4Mayo Clinic, Rochester, MN, 5University of Maryland Baltimore, Baltimore, MD, 6Yale School of Medicine, WOODBRIDGE, CT, 7Alaska Native Tribal Health Consortium, Anchorage, AK, 8Piedmont Healthcare, Atlanta, GA, 9Seattle Children's Hospital, Seattle, WA, 10Lupus Foundation of America, Inc, Washington, DC, 11Medstar Georgetown University Hospital, District Heights, MD, 12University of Colorado Anschutz Medical Campus, Denver, CO, 13Yale School of Medicine, New Haven, CT, 14Dignity Health-MMG Rheumatology, Citrus Heights, CA, 15University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Achieving health equity has been a long-standing goal, as Academy of Medicine leaders stated, ‘There is no equity without quality, and there is no…
  • Abstract Number: 0182 • ACR Convergence 2024

    Pilot Volunteer Lupus Navigator Program – Leveraging Community Health Workers to Address Social Determinants of Health in SLE

    Patricia Nogueira De Sa1, Stephanie Wirtshafter1, Abdallah Geara2 and Kimberly DeQuattro2, 1University of Pennsylvania, Pennsylvania, 2University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic, multisystem autoimmune condition that disproportionally affects individuals from racial and ethnic minority groups with more than 95%…
  • Abstract Number: 0616 • ACR Convergence 2024

    Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus

    Victoria Delk1, Dulaney Wilson2, Gary Gilkeson2, Jim Oates2 and Diane Kamen2, 1Medical University of South Carolina, North Charleston, SC, 2Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with the potential to severely diminish patients' quality of life (QoL). SLE disproportionately affects young…
  • Abstract Number: 1030 • ACR Convergence 2024

    Diversity in Axial Spondyloarthritis Drug Trials: Examining Enrollment by Sex, Race, Ethnicity and Geographic Region

    Mathieu Choufani1, Wissam Ghusn2 and Joerg Ermann3, 1Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, 2Department of Internal Medicine, Boston Medical Center, Boston, MA, 3Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: While axial spondyloarthritis (AxSpA) was historically perceived as a "white man's disease", it is now appreciated as a condition that can affect individuals of…
  • Abstract Number: 1916 • ACR Convergence 2024

    Healthcare Disparities and Clinical Outcomes in Cardiac Sarcoidosis. a Retrospective Cohort Study

    Yurilu Gonzalez Moret1, Diego Lema2, kevin Lo3 and Fabian Rodriguez Quinonez4, 1Jefferson Einstein Hospital, Philadelphia, PA, 2Universidad Central de Venezuela, University of Wisconsin, Philadelphia, PA, 3Brigham and Women's Hospital, Boston, MA, 4Einstein Medical Center Philadelphia, Philadelphia, PA

    Background/Purpose: Sarcoidosis is a condition affecting multiple organ systems, characterized by the presence of non-caseating granulomas. Cardiac sarcoidosis (CS) is a challenging diagnosis, with a…
  • Abstract Number: 2552 • ACR Convergence 2024

    Changes in Social Determinants of Health Needs Uncovered by a Rheumatology-Based Screening and Assistance Program

    Haelynn Gim1, Rebecca Summit2, Karli Retzel2, Leah Santacroce2, Virginia Bills3, Nancy Shadick2, Sara Schoenfeld4 and Candace Feldman2, 1Harvard Medical School, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3Mass General Brigham, Boston, MA, 4Massachusetts General Hospital, Boston, MA

    Background/Purpose: Social determinants of health (SDoH), including non-medical social needs and adverse environmental exposures, contribute to inequities in rheumatic disease care and outcomes. Patients with…
  • Abstract Number: 0185 • ACR Convergence 2024

    New and Severe Damage in a Prevalent Lupus Cohort Through the Lens of Demographic and Neighborhood Disparities

    Jonathan Katz1, Ang Yu2, Felix Elwert2, Robert Greenlee3, David Gazeley4, Ann Rosenthal5, Jenna Cormier5, Bryn Sutherland5, Shalvi Parikh6, Yiran Jiang7 and Christie Bartels8, 1University of Wisconsin Hospitals and Clinics, Madison, WI, 2University of Wisconsin-Madison, Madison, WI, 3Marshfield Clinical Research Institute, Marshfield, WI, 4Medical College of Wisconsin, Wauwatosa, WI, 5Medical College of Wisconsin, Milwaukee, WI, 6Mississippi Delta Family Medicine Residency, Greenville, MS, 7Annapolis Rheumatology, Washington, DC, 8University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Systemic Lupus Erythematosus (SLE) disproportionally affects minoritized populations.  SLE damage, assessed by SLICC/ACR Damage Index (SDI), is higher in Black than in White US…
  • Abstract Number: 0619 • ACR Convergence 2024

    Prevalence and Factors Predicting Hemophagocytic Lymphohistiocytosis in Hospitalized Patients with Systemic Lupus Erythematosus

    OKEOGHENE AKPOIGBE1, BETTINA ESCOLANO2, ENOCH J ABBEY2 and Amanda Sammut3, 1New York City Health and Hospitals/Harlem in Affliation with Columbia University, NEW YORK, NY, 2New York City Health and Hospitals/Harlem in Affliation with Columbia University, NEW YORK, 3New York City Health and Hospitals/Harlem. Rheumatology Department, Chappaqua, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) complicated with hemophagocytic lymphohistiocystosis (HLH) can be life-threatening with mortality as high as 9.9%-10.5%. Estimates of the prevalence of HLH…
  • Abstract Number: 1031 • ACR Convergence 2024

    Access to Advanced Therapies in Axial Spondyloarthritis in Latin America, Data from the PANLAR-ESPALDA Registry

    Rodrigo Garcia Salinas1, Fernando Andres Sommerfleck2, Diego Vila3, Daniel Palleiro4, Daniel Fernández-Ávila5, Julio César Casasola Vargas6, Maria Amada Barcia7, Dora Liliana Candia Zuniga8, Nicolas Martin Marin Zucaro9, María Lorena Brance10 and Wilson Bautista-Molano11, 1Hospital Italiano La Plata, La Plata, Argentina, 2Sanatorio Julio Mendez, Buenos Aires, Argentina, 3Hospital Virgen del Carmen, Campana, Buenos Aires, Argentina, 4Instituto Nacional de Reumatologia, Montevideo, Uruguay, 55Hospital San Ignacio, Colombia, BOGOTA, Colombia, 6Hospital General de México, “Dr.Eduardo Liceaga”, MEXICO CITY, Mexico, 77Hospital General Portoviejo del Instituto Ecuatoriano de Seguridad Social (IESS), Guayaquil, Ecuador, 88Hospital Regional Primero de Octubre ISSTE, Fuerzas Armadas, Mexico City, Mexico, 9Hospital Italiano de Buenos Aires, Capital Federal, Argentina, 10School of Medicine, Rosario National University, Argentina, Rosario, Argentina, 11University Hospital Fundación Santa Fe de Bogotá, Bogotá, Colombia

    Background/Purpose: Access to advanced treatments in LATAM poses challenges due to various socioeconomic factors. The PANLAR-ESPALDA registry was established with the objective of gathering data…
  • Abstract Number: 1917 • ACR Convergence 2024

    Access to Rheumatology Care near Indian Health Service Hospitals for American Indian Communities

    Tristan Furnary1, Rachel Wallwork2, Megan Lockwood3, Brooke Montgomery4, Caleb Bolden4, Siobhan Wescott5, Matthew Tobey4 and Marcy Bolster4, 1Harvard Medical School, Brookline, MA, 2Johns Hopkins University, Towson, MD, 3Medstar Georgetown University Hospital, Washington, DC, 4Massachusetts General Hospital, Boston, MA, 5University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Geographic barriers to subspecialty care among American Indian (AI) populations are poorly defined. Mapping the geographic distribution of rheumatology providers is a crucial step…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology